The Hsp90-specific inhibitor, geldanamycin, blocks CD28-mediated activation of human T lymphocytes.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/9EE4CF2B.svg?ark=w1%2F20260515%2F9EE4CF2B)](https://nobleid.org/work/w1/20260515/9EE4CF2B)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors